DOP57 Vedolizumab has similar efficacy rates in young and...

Journal of Crohn's and Colitis 2020 / 01 Vol. 14; Iss. Supplement

DOP57 Vedolizumab has similar efficacy rates in young and elderly patients: A binational, multicentre, retrospective case–control study

Cohen, N A, Plevris, N, Kopylov, U, Grinman, A, Ungar, B, Yanai, H, Leibovitzh, H, Fliss, N, Hirsch, A, Ritter, E, Ron, Y, Bar-Gil Shitrit, A, Goldin, E, Dotan, I, Ben-Horin, S, Lees, C, Maharshak, N
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjz203.096
Date:
January, 2020
File:
PDF, 2.74 MB
2020
Conversion to is in progress
Conversion to is failed